# Wallac Oy, A Subsidiary of Perkinelmer, Inc.

- Location (FDA's records): Waltham, MA
- FDA decisions: 4 (2011–2018): 4 510(k) clearances
- Names in FDA's records: Wallac Oy, A Subsidiary of Perkinelmer, Inc. (3); Wallac Oy, A Subsidiary of Perkinelmer (1)
- Product codes: JNO (1), KLI (1), PQW (1), JIA (1)
- Predicates its devices cite: 4 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Wallac OY: 3 (https://510kreport.com/company/wallac)
- Baebies, Inc.: 1 (https://510kreport.com/company/baebies)

## Firms that cite its devices most
- Perkinelmer, Inc.: 2 (https://510kreport.com/company/perkinelmer)

## Its most-cited devices
- K173829: NeoLSD MSMS kit (2018), cited by 1
- K133652: GSP Neonatal Total Galactose Kit (2014), cited by 1

## Recent decisions
- K173829: NeoLSD MSMS kit (Jul 18, 2018)
- K133652: GSP Neonatal Total Galactose Kit (Apr 28, 2014)
- K110274: Autodelfia Neonatal Irt Kit (Jun 10, 2011)
- K103484: GSP Neonatal Thyroxine (T4) (Apr 22, 2011)

Source page: https://510kreport.com/company/wallac-oy-a-subsidiary-of-perkinelmer